These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8551100)

  • 1. [Effect of h-PTH on bone and bone marrow tissue in experimental osteopenia in rat].
    Ishigaki S
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):992-1003. PubMed ID: 8551100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of intermittent administration of human PTH on experimental osteopenia in adult rat: a histomorphometric study of both trabecular and cortical bone of the vertebrae].
    Narita Y
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1027-36. PubMed ID: 8551088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of human PTH on steroid-induced osteopenia: a histomorphometric study of decalcified and undecalcified trabecular bone sections in rat].
    Unoki E
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1064-75. PubMed ID: 8551091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone histomorphometric osteopenia induced by ovariectomy or diabetes mellitus in rat].
    Nagasawa T
    Nihon Seikeigeka Gakkai Zasshi; 1995 Sep; 69(9):699-707. PubMed ID: 8530885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT; Chan C; Müller K
    J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of h-PTH on cancellous bone mass, connectivity, and bone strength in ovariectomized rats with and without sciatic-neurectomy.
    Kasukawa Y; Miyakoshi N; Itoi E; Tsuchida T; Tamura Y; Kudo T; Suzuki K; Seki A; Sato K
    J Orthop Res; 2004 May; 22(3):457-64. PubMed ID: 15099621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats.
    Andersson N; Surve VV; Lehto-Axtelius D; Andersson K; Ryberg B; Ohlsson C; Håkanson R
    Acta Orthop Scand; 2004 Apr; 75(2):201-9. PubMed ID: 15180236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
    J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
    Shirota T; Tashiro M; Ohno K; Yamaguchi A
    J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
    J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.